G-CSF-transduced stem cell therapy (Stemedica)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug NameG-CSF-transduced stem cell therapy (Stemedica)
Drug Alias NameN/A
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Mesenchymal stem cells therapy
Mechanisms of ActionColony stimulating factor 3 receptor agonists
TargetsColony stimulating factor 3 receptor
Therapy Area/IndicationsIschemic Stroke
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesStemedica Cell Technologies Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesStemedica Cell Technologies Inc
Active IndicationsN/A
Inactive IndicationsIschemic Stroke

Other Information

ATC CodeN/A
Related LinksN/A